Our mission is to develop novel therapeutics and biomarkers for liver cancer. We conduct basic and translational research using genomic data from human HCC, mouse models of liver cancer, and patient derived xenografts. We are deciphering the molecular biology of hepatocellular carcinoma (HCC) using innovative methods, cutting-edge techniques, and interdisciplinary collaborative approach. Furthermore, recruiting and training the future generation of researchers is a key component of our mission
Discover a cure for liver cancer through innovative experimentation.